|
|
(11 intermediate revisions by 2 users not shown) |
Line 1: |
Line 1: |
− | {{Newcastle/navbar}} | + | {{Newcastle/navbar2}} |
| <html> | | <html> |
| | | |
Line 40: |
Line 40: |
| Hydroponics | | Hydroponics |
| </a> | | </a> |
− | <a href="#construct" class="smoothscroll btn btn--stroke"> | + | |
− | Naringenin Operon
| + | |
− | </a>
| + | |
− | <a href="#operon" class="smoothscroll btn btn--stroke">
| + | |
− | Improved Operon
| + | |
− | </a>
| + | |
| </div> | | </div> |
| | | |
Line 116: |
Line 111: |
| | | |
| </section> <!-- end s-about --> | | </section> <!-- end s-about --> |
− |
| |
− | <!-- services
| |
− | ================================================== -->
| |
− | <section id='construct' class="s-services">
| |
− | <div class="row section-header has-bottom-sep" data-aos="fade-up">
| |
− | <div class="col-full">
| |
− | <h3 class="subhead">Naringenin Operon</h3>
| |
− | <h1 class="display-1">DESIGN</h1>
| |
− | </div>
| |
− | </div> <!-- end section-header -->
| |
− |
| |
− | <div class="row about-desc" data-aos="fade-up">
| |
− | <div class="col-full">
| |
− | <p class="about-para"> In order to produce the flavonoid naringenin, construction of a naringenin operon that would be synthesised from the sequence in the iGEM parts registry to gblocks by IDT was required. This operon was based on that used by the TU Darmstadt 2014 iGEM team, allowing the production of naringenin to attract nitrogen fixing bacteria. It contains the genes for four enzymes: 4 – Coumaryl ligase, Tyrosine ammonia lyase, Chalcone isomerase and Chalcone synthase. Each of these genes will contain a strong ribosome binding site. This construct will be under the control of a J23100 constitutive promoter to observe its expression in <i>Escherichia coli</i> as a proof of concept. Once biosynthesis under the control of J23100 is achieved, the construct future experiments would test this under a T7 promoter in E. coli. Parts for biosynthesis in the final chassis organism, root-colonising <i>Pseudomonas fluorescens</i>, will be constructed in the plasmid backbone pSB1C3.</p>
| |
− |
| |
− | </div>
| |
− | </div> <!-- end project-desc -->
| |
− |
| |
− | <div class="row services-list block-1-2 block-tab-full">
| |
− |
| |
− | <div class="col-block service-item" data-aos="fade-up">
| |
− | <div class="service-icon">
| |
− | <i class="icon-paint-brush"></i>
| |
− | </div>
| |
− | <div class="service-text">
| |
− | <img src="https://static.igem.org/mediawiki/2018/e/e8/T--Newcastle--j23100plasmid.jpeg">
| |
− | <p style="text-align:center"><br> The naringenin biosynthetic operon under control of a J23100 promoter created in Benchling.</p>
| |
− |
| |
− | </div>
| |
− | </div>
| |
− |
| |
− | <div class="col-block service-item" data-aos="fade-up">
| |
− | <div class="service-icon">
| |
− | <i class="icon-paint-brush"></i>
| |
− | </div>
| |
− | <div class="service-text">
| |
− | <img src="https://static.igem.org/mediawiki/2018/d/d6/T--Newcastle--t7plasmid.jpeg">
| |
− | <p style="text-align:center"><br>The naringenin biosynthetic operon under control of a T7 promoter created in Benchling.</p>
| |
− |
| |
− |
| |
− | </div>
| |
− | </div>
| |
− | <div class="row services-list block-1-2 block-tab-full">
| |
− |
| |
− | <div class="col-block service-item" data-aos="fade-up">
| |
− | <div class="service-icon">
| |
− | <i class="icon-paint-brush"></i>
| |
− | </div>
| |
− | <div class="service-text">
| |
− | <img src="https://static.igem.org/mediawiki/2018/9/95/T--Newcastle--SBOLJ23100.jpeg">
| |
− | <p style="text-align:center"><br> The naringenin biosynthetic operon under control of a J23100 promoter created in Benchling.</p>
| |
− |
| |
− | </div>
| |
− | </div>
| |
− |
| |
− |
| |
− | </div> <!-- end services-list -->
| |
− |
| |
− | </section> <!-- end s-services -->
| |
− |
| |
− |
| |
− | <!-- about
| |
− | ================================================== -->
| |
− | <section id='operon' class="s-about">
| |
− | <div class="row section-header has-bottom-sep" data-aos="fade-up">
| |
− | <div class="col-full">
| |
− | <h3 class="subhead subhead--dark">Improved Naringenin Operon based on Pathway Modelling</h3>
| |
− | <h1 class="display-1 display-1--light">DESIGN</h1>
| |
− | </div>
| |
− | </div> <!-- end section-header -->
| |
− |
| |
− | <div class="row about-desc" data-aos="fade-up">
| |
− | <div class="col-full">
| |
− | <p class="about-para"> Results of the modelling showed that weaker expression of the first two genes and 10 fold stronger expression of the last two genes would reduce the build-up of malonyl CoA and optimise naringenin synthesis. Therefore we found two synthetic promoters: BG28 and BG51 and an additional <i>E. coli</i> his operon terminator to be placed after the first two genes. These will allow enhanced naringenin production in future experiments, as BG28 is a weak promoter for the first two genes and BG51 is a strong promoter for the last two.</p>
| |
− |
| |
− | </div>
| |
− | </div> <!-- end project-desc -->
| |
− |
| |
− | <div class="col-block service-item" data-aos="fade-up">
| |
− | <div class="service-icon">
| |
− | <i class="icon-paint-brush"></i>
| |
− | <img src="https://static.igem.org/mediawiki/2018/e/ed/T--Newcastle--BGplasmid.jpeg">
| |
− | </div>
| |
− | <div class="service-text">
| |
− | <p style="text-align:center"><br>The naringenin biosynthetic operon under control of synthetic promoters BG28 and BG51 created in Benchling.</p>
| |
− |
| |
− | </div>
| |
− | </div>
| |
− |
| |
− | <div class="col-block service-item" data-aos="fade-up">
| |
− | <div class="service-icon">
| |
− | <i class="icon-paint-brush"></i>
| |
− | </div>
| |
− | <div class="service-text">
| |
− | <img src="https://static.igem.org/mediawiki/2018/c/c8/T--Newcastle--BGcloseup.jpeg">
| |
− | <p style="text-align:center"><br>A close up of the synthetic promoters BG28 and BG51 placement in the operon, created in Benchling.</p>
| |
− |
| |
− | </div>
| |
− | </div>
| |
− |
| |
− | <!-- </div> end about-list -->
| |
− |
| |
− | </section> <!-- end s-about -->
| |
| | | |
| <!-- Java Script | | <!-- Java Script |